Sarepta Therapeutics, Inc. (SRPT) Earnings
NASDAQ·Healthcare·Biotechnology
$21.12
+0.67%
Mkt Cap $2.17B
Next Earnings
In 7 daysWed, May 6, 2026
EPS Estimate
$0.98
8 analysts
Revenue Estimate
$474.16M
Last quarter: missed by -247.57% on EPS, +19.84% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$2.17B
P/E
—
Fwd P/E
9.48
P/S
0.99
Rev TTM
—
EPS TTM
-$8.44